Insider filing · NMRA
Kristina Burow
Director
profile →
Neumora Therapeutics, Inc.
NMRA · Healthcare · 5 filings in 24 months
ticker →
Kristina Burow bought $5.0M of Neumora Therapeutics (NMRA)
Executed Oct 27 2025, disclosed Oct 29 2025, 2 days later.
Value, as filed
$5.0M
1,915,700 sh × $2.61
Executed
Oct 27 2025
the trade date, as filed
Disclosed
Oct 29 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
-11.9%
-19.5% from execution
Over the 21 trading sessions from the disclosed entry session (Oct 29 2025), the stock returned -11.9% (delay-adjusted); from the execution session (Oct 27 2025), -19.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
KBKristina Burow (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Scholar Rock Holding Corporation (SRRK). The largest single filing was $113K of SRRK (2,105 sh × $53.49, as filed), executed Jul 1.
The name
NMRAHealthcare · Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, ne…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→